Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
19,139,638
-
Share change
-
+8,147,645
-
Total reported value
-
$153,117,000
-
Price per share
-
$8.00
-
Number of holders
-
32
-
Value change
-
+$63,511,328
-
Number of buys
-
28
-
Number of sells
-
4
Institutional Holders of AC Immune SA - SHS (ACIU) as of Q3 2018
As of 30 Sep 2018,
AC Immune SA - SHS (ACIU) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,139,638 shares.
The largest 10 holders included
FMR LLC, Temasek Holdings (Private) Ltd, Duquesne Family Office LLC, BVF INC/IL, JANUS HENDERSON GROUP PLC, ORBIMED ADVISORS LLC, Artal Group S.A., PointState Capital LP, Balyasny Asset Management LLC, and SPHERA FUNDS MANAGEMENT LTD..
This page lists
32
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.